North Capital’s Labcorp LH Stock Holding History

North Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-105	Closed	-$30.1K	–	431
2025 Q3	$30.1K	Buy	105 +4	+4%	+$1.07K	0.02%	268
2025 Q2	$26.5K	Sell	101 -16	-14%	-$3.9K	0.02%	277
2025 Q1	$27.2K	Buy	+117	New	+$28.4K	0.03%	263

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

North Capital's LH Position: Q4 2025 in Review

North Capital sold out of Labcorp (LH) in Q4 2025, closing a stake of 105 shares — an estimated $30.1K sold.

North Capital first reported a position in LH in Q1 2025 and held it in 3 quarters. The position peaked at $30.1K in Q3 2025. 1,028 funds tracked by Wall St. Rank hold LH as of Q4 2025.

North Capital reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
North Capital sold 105 Labcorp shares in Q4 2025, an estimated $30.1K.
North Capital first reported a position in Labcorp in Q1 2025 and held it in 3 quarters.
North Capital's Labcorp position peaked at $30.1K in Q3 2025.
1,028 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.